Back to VRTX Stock Lookup
Pages: 1 2 3 4 5 »» Last Page

VRTX Related Analyst Ratings

May 2, 2013 01:45 PM Vertex (VRTX) VX-135 Looks Interesting, Thinks Deutsche Bank
Apr 19, 2013 07:25 AM Vertex (VRTX) PT Goes to $95 at Needham & Company after Strong Data
Apr 19, 2013 07:10 AM Goldman Sachs Upgrades Vertex (VRTX) to Neutral after 661/Kalydeco Combo Data
Apr 19, 2013 06:58 AM Canaccord Genuity Upgrades Vertex (VRTX) to Buy
Apr 18, 2013 05:15 PM Significant Upside in Vertex (VRTX) Warranted, Says Wells Fargo
Apr 10, 2013 07:25 AM Chardan Capital Starts Vertex (VRTX) at Buy
Apr 8, 2013 07:21 AM Canaccord Genuity Starts Vertex (VRTX) at Hold
Mar 28, 2013 12:32 PM Sales of Gilead (GILD) HCV Treatment Could Top $6B in U.S. Alone - Analyst
Feb 27, 2013 12:02 PM Goldman Thinks Vertex (VRTX) Overvalued, Maintains Sell
Feb 7, 2013 09:24 AM Baird Starts Vertex (VRTX) at Outperform
Jan 15, 2013 06:43 AM Lazard Capital Downgrades Vertex (VRTX) to Neutral
Jan 2, 2013 05:49 PM Janney Montgomery Scott Starts Vertex (VRTX) at Buy
Dec 13, 2012 03:34 PM Goldman Says Expect More Downside in Vertex Pharmaceuticals (VRTX)
Nov 28, 2012 07:43 AM Argus Downgrades Vertex (VRTX) to Hold
Nov 27, 2012 01:18 PM Well Fargo on Vertex (VRTX) Hidden Pipeline - VX-787 for Influenza
Nov 12, 2012 07:04 AM Credit Suisse Downgrades Vertex (VRTX) to Neutral
Nov 2, 2012 07:56 AM Goldman Sachs Downgrades Vertex (VRTX) to Sell; Becomes More Cautious on CF Combo Program
Oct 12, 2012 08:29 AM Analyst Says Vertex (VRTX) Drug Data Shows "At Least Moderate Impact"
Oct 9, 2012 07:03 AM Deutsche Bank Starts Vertex (VRTX) at Buy, Confidence in CF Program to Increase
Oct 4, 2012 03:17 PM NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst
Oct 4, 2012 03:02 PM Argus Starts Vertex (VRTX) at Buy
Sep 10, 2012 12:55 PM UBS on U.S. Biotechnology - Updating Outlook on Covered Stocks (GILD, AMGN, BIIB, CELG, INCY, IDIX, VRTX, SGEN)
Aug 30, 2012 06:47 AM ThinkEquity Starts Vertex (VRTX) at Buy
Aug 29, 2012 01:05 PM Brean Murray Carret & Co. Maintains a 'Buy' on Vertex (VRTX); Eyes on Kalydeco
Aug 29, 2012 01:05 PM Brean Murray Carret & Co. Maintains a 'Buy' on Vertex (VRTX); Eyes on Kalydeco
Aug 17, 2012 02:54 PM Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)
Aug 7, 2012 07:51 AM Lazard Capital Starts Vertex (VRTX) at Buy
Jul 31, 2012 01:27 PM UBS Cuts Estimates on Vertex (VRTX): Keep 'Buy' Thesis and Bullish View
Jul 31, 2012 08:31 AM Needham & Company Reiterates a 'Buy' on Vertex (VRTX); Incivek Sales Continue to Fall, But Initial ALS-2200 Data Are Encouraging
Jul 31, 2012 08:09 AM Piper Jaffray Downgrades Vertex (VRTX) to Neutral
Jul 18, 2012 01:10 PM Needham & Company Maintains a 'Buy' on Vertex (VRTX); Adjusting Q2 Lower, But Positive on Cash Flow
Jul 10, 2012 09:55 AM Bernstein Sees Promising Efficacy for Vertex's (VRTX) Oral RA Treatment; Shares Tick Higher
Jun 29, 2012 08:16 AM Needham & Company Reiterates a 'Buy' on Vertex (VRTX); Combination Trial in CF Encouraging
Jun 28, 2012 01:18 PM Wells Fargo Reiterates an 'Outperform' on Vertex (VRTX); Successful Phase III Could Have Multi-Billion Dollar Potential
Jun 27, 2012 10:46 AM Maxim Group Starts Vertex (VRTX) at Buy
Jun 11, 2012 03:56 PM Barclays Defends Vertex (VRTX): A Few Concerns, But Making Moves In The Right Direction
May 29, 2012 10:35 AM Needham & Company Maintains Bullish Stance on Vertex (VRTX) Despite Weaker Data
May 29, 2012 09:22 AM Wells Fargo Maintains an 'Outperform' on Vertex (VRTX); Data Not Quite As Strong, But Combo Still Clearly Active
May 25, 2012 01:40 PM Barclays Remains Bullish on Vertex (VRTX); Upside to Phase I Data
May 14, 2012 07:54 AM JPMorgan Upgrades Vertex (VRTX) to Overweight
May 11, 2012 01:26 PM Barclays on Healthcare: Top Takeaways from our Second Annual Therapeutics Symposium
May 10, 2012 08:09 AM RBC Capital Downgrades Vertex (VRTX) to Outperform
May 8, 2012 03:50 PM Leerink Swann Maintains an 'Outperform' on Vertex (VRTX); CF Conference Call Affirms Opportunity
May 8, 2012 01:47 PM Barclays Maintains an 'Overweight' on Vertex (VRTX); Raising PT to $77
May 8, 2012 08:00 AM Needham & Company Upgrades Vertex (VRTX) to Buy; Positive Interim VX-809/Kalydeco Results; Large Market Opp
May 8, 2012 07:34 AM Wells Fargo Upgrades Vertex (VRTX) to Outperform; Compelling CF Combo Data
May 8, 2012 06:56 AM Morgan Stanley Upgrades Vertex (VRTX) to Equalweight
May 7, 2012 03:48 PM Brean Murray Issues Mid-Day Upgrade on Vertex Pharma (VRTX)
May 7, 2012 10:47 AM JMP Securities Upgrades Vertex (VRTX) to Market Outperform
May 7, 2012 08:59 AM ISI Group Upgrades Vertex (VRTX) to Buy
Pages: 1 2 3 4 5 »» Last Page

Back to VRTX Stock Lookup